Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001567619-18-002811

CEO sold 29,539 shares at $65.00 ($1,920,035)

  • CEO acquired 29,539 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Abdun-Nabi Daniel CEO 2018-09-14 Option exercise +28,220 $13.38 $377,584 194,787 D: show line 1 in the form
Abdun-Nabi Daniel CEO 2018-09-14 Sale −28,220 $65.00 $1,834,300 166,567 D: show line 2 in the form
Abdun-Nabi Daniel CEO 2018-09-17 Option exercise +1,319 $13.38 $17,648 167,886 D: show line 3 in the form
Abdun-Nabi Daniel CEO 2018-09-17 Sale −1,319 $65.00 $85,735 166,567 D: show line 4 in the form
Open-market sales · 29,539 sh · avg $65.00 · $1,920,035

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Abdun-Nabi Daniel CEO 2018-09-14 Option exercise · Stock Option (Right to Buy) +28,220 1,319 D: show line 5 in the form
Abdun-Nabi Daniel CEO 2018-09-17 Option exercise · Stock Option (Right to Buy) +1,319 0 D: show line 6 in the form
Loading xslF345X03/doc1.xml…